Author: healthadmin

Tracking smartphones over time reveals how deeply embedded they are in school life. Some teens check their phones more than 140 times, and frequent checking is associated with poor cognitive control. Study: Association between smartphone use and cognitive control during school hours in adolescents aged 11 to 18 years. Image credit: Ground Picture/Shutterstock.com Research published in JAMA network open found that adolescents frequently used smartphones during class and frequently checked their phones, which was associated with decreased cognitive control. The study found that some students checked their phones more than 140 times during school hours, with the highest frequency being…

The FDA has rejected Hyloris Pharmaceuticals’ antiviral drug valacyclovir, an oral suspension for infections caused by the herpes simplex virus and the varicella-zoster virus. In a Complete Response Letter (CRL), the FDA said it identified the issue through testing of a third-party manufacturer of gray squirrels. U.S. regulators have not identified any issues in the CRL and explained that the issues have been itemized to representatives of production facilities. CRL was not surprising. Belgium-based Hylolith said in a release last month that the FDA assigned the Greek facility an Official Action Instruction (OAI) classification after inspection (PDF). OAI is the…

Mass General Brigham researchers have developed a set of artificial intelligence (AI) tools that use machine learning to use information from electronic medical records (EMRs) to identify individuals who may be at risk for intimate partner violence (IPV). In a study published in npj women’s health, Researchers reported that the tool was able to detect IPV up to four years before an individual sought care at a domestic violence treatment center. This finding highlights proactive screening and its potential to support health care providers in initiating early conversations with patients about IPV. Our study provides proof of concept that…

Despite clear improvements in patient outcomes, adherence to clinical practice guidelines in the management of rare cancers remains inconsistent across Europe, an analysis jointly conducted by ESMO and EURACAN, the European Reference Network for Rare Cancers (ERN), shows. The results, presented today at the ESMO Sarcoma and Rare Cancers Conference 2026, highlight the opportunity for physicians and public health policy makers to improve outcomes by standardizing and centralizing care for patients with rare malignancies. Together, the number of new cases of rare malignancies exceeds 650,000 per year, representing a quarter (24%) of all cancer diagnoses in Europe each year. Delayed…

In this interview, NewsMed speaks with Georgia Golfis, European Imaris team principal, about the launch of Imaris 11 and how its new workflow-driven approach is transforming image analysis through automation, reproducibility, and intelligent batch processing. Could you please introduce yourself and your role at Imaris? My name is Georgia Golfis and I’m part of the European Imaris team. I work closely with users to support their image analysis needs and help them get the most out of their software. New versions of Imaris are typically presented by product manager Anna Paszulewicz, who oversees development from concept to launch. We have…

Researchers from Flinders University and Flinders Medical Center have identified a significant association between two common types of intestinal polyps and an increased risk of cancer. Their findings will be published in a magazine Clinical gastroenterology and hepatology (CGH). Bowel cancer, also known as colorectal cancer, is a serious health concern. In Australia, it is the second leading cause of cancer death and ranks fourth in terms of the number of cancers diagnosed. Many colorectal cancers start as polyps, which are growths that form on the lining of the intestines. These tumors are usually benign and do not cause immediate…

Eli Lilly has investments in China, Japan, and South Korea. Pfizer has become obese thanks to Chinese consent from local partner Cywind Biosciences. Astellas Pharma’s CEO said the higher-than-expected reimbursement price in Japan was thanks to the U.S. most-favored-nation policy. moreover. 1. Lilly boosts oral GLP-1 production capacity with $3 billion manufacturing commitment in China Eli Lilly is investing $3 billion in China over the next 10 years to strengthen manufacturing capacity for its pipeline, including the GLP-1 tablet Orforglipron, which is under review in more than 40 countries, including China and the United States. The first part of the…

When comparing people who suffer from social anxiety disorder to people who don’t, it was found that there was no difference in the number of sexual interactions they had. However, people without social anxiety tended to have higher levels of positive affect the day after the sexual interaction. This was not the case for individuals suffering from social anxiety disorder. The paper is cognitive behavioral therapy. Social anxiety disorder is a mental health condition characterized by an intense fear of being judged, embarrassed, or negatively evaluated in social situations. People with this disorder worry excessively about how they appear to…

Get the health information and medications you need every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Here are some important questions for you this Friday morning. How long will you continue playing Survivor? Unrelated, but equally important: What is the connection between surrealism and dementia? Scroll down to find out. Will the White House be able to distance itself from vaccine skepticism? Secretary of Health Robert F. Kennedy Jr. spent his first year in office overhauling the federal government’s approach to vaccines. White House officials are trying to stop him and his Make America Healthy Again allies.…

Announcement of new article publication BIO integration journal. Clinical trials bridge the gap between basic research and clinical application and serve as an important step in drug development. This review examines the phases of clinical trials: Phase I (safety assessment), Phase II (efficacy assessment), Phase III (large-scale validation), and Phase IV (postmarket surveillance), and focuses on unique features and interactions. Key challenges such as ethical compliance, participant recruitment, and ensuring diversity and representativeness of study populations are identified, while evidence-based mitigation strategies are proposed. To address these challenges, innovative technologies such as artificial intelligence, big data analytics, and digital health…